InsidersTradesSigma
Explore the full insider trade history of Jade Biosciences, Inc., a publicly traded company based in United States. Shares trade on US US, under the oversight of SEC (Form 4). Market capitalisation: €883m. The latest transaction was disclosed on 19 May 2025 (Acquisition). Among the most active insiders: Frohlich Tom. The full history is free.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
2 of 2 declarations